eed to visit =evin's lab. I wanted the data, the evidence. I don't like hot air." He =ent to Tak, the lead scientist for the trials. "I asked him, 'Paul-Peter, is =t really real?'" After getting =n endorsement from Tak, who is now Glaxo's global head of immuno-inflammation research, Slaoui committed to fi